Credelio is FDA-approved and considered safe for most dogs. It’s a monthly chewable flea and tick medication cleared for puppies as young as 8 weeks old and weighing at least 4.4 pounds. That said, it belongs to a drug class that carries a specific FDA warning about rare neurological side effects, so there are a few things worth understanding before you give it to your dog.
What Credelio Does and How It Works
Credelio’s active ingredient, lotilaner, kills adult fleas and controls five species of ticks, including the lone star tick, American dog tick, black-legged tick, brown dog tick, and longhorned tick. Protection lasts one month per dose.
The drug works by blocking a specific nerve-signaling channel in insects and ticks, essentially paralyzing and killing them. The key to its safety in dogs is selectivity: when tested in the lab, lotilaner did not affect the same signaling channels in mammals, even at high concentrations. That’s why it can be lethal to parasites while remaining well-tolerated by your dog.
Common Side Effects
In a field study of 191 dogs given Credelio Quattro (which contains lotilaner alongside other active ingredients), the most frequently reported side effects were:
- Diarrhea (sometimes with blood): 11% of dogs
- Vomiting: 9.4%
- Lethargy: 6.3%
- Loss of appetite: 5.8%
These reactions are generally mild and short-lived. Roughly 1 in 10 dogs experienced some GI upset, which is comparable to many other oral flea and tick products. If your dog vomits within a couple of hours of taking the tablet, you may need to redose, so it’s worth watching them after administration.
The FDA’s Neurological Warning
Credelio belongs to a drug class called isoxazolines, which also includes other popular flea and tick products. The FDA has issued a class-wide alert noting that isoxazolines have been associated with neurological reactions in some dogs, including muscle tremors, loss of coordination (ataxia), and seizures.
The FDA is clear that these events are uncommon and that the majority of dogs tolerate isoxazolines without neurological issues. However, seizures have occurred even in dogs with no prior seizure history. That’s what makes this worth knowing about: there’s no reliable way to predict which dogs will react.
If your dog has a history of seizures or a neurological condition, this is an especially important conversation to have with your vet. For dogs without that history, the risk appears low, but it isn’t zero.
Age, Weight, and Breed Restrictions
Credelio is approved for dogs and puppies at least 8 weeks old and weighing 4.4 pounds or more. It has not been evaluated in dogs younger or smaller than that, so it should not be used in very young or very small puppies. The product comes in weight-banded tablet sizes, so your dog needs to be weighed accurately to get the right dose.
There’s no breed-specific restriction on the label, but breeds known to carry a gene mutation affecting a protein called P-glycoprotein (common in Collies, Australian Shepherds, and related herding breeds) deserve extra caution. Lotilaner is a substrate for P-glycoprotein, which means dogs with reduced function of this protein may process the drug differently. If your dog is a herding breed or a mix of one, mention it when discussing flea and tick options.
Interactions With Other Medications
Lotilaner can interact with other drugs that rely on the same transport protein (P-glycoprotein) to move through the body. This includes certain heart medications and some chemotherapy drugs. Using Credelio alongside these medications could increase the risk of side effects from either drug.
In clinical settings, Credelio has been used alongside common vaccines, dewormers, and other routine medications without notable problems. Still, if your dog takes any long-term medication, let your vet know before starting Credelio so they can check for potential interactions.
How It Compares to Other Flea and Tick Options
Credelio’s safety profile is broadly similar to other isoxazoline products on the market. They all share the same FDA class warning about neurological events, and they all work through the same basic mechanism. The differences between them come down to specifics: which tick species they cover, how long each dose lasts, whether they also prevent heartworm or intestinal parasites, and whether they come as a chewable or a topical.
For dogs that can’t tolerate oral medications or have a seizure history, non-isoxazoline alternatives exist, including certain topical treatments and tick collars that use different drug classes. These come with their own trade-offs in terms of effectiveness and convenience, but they avoid the isoxazoline-specific neurological concern.
Giving Credelio Effectively
Credelio is a flavored chewable tablet given once a month. One practical detail that’s easy to miss: it should be given with food. Administering the tablet with a meal improves absorption, which means the drug reaches effective levels in your dog’s bloodstream more reliably. Giving it on an empty stomach could reduce how well it works.
Each dose provides protection for a full month, so consistent timing matters. Gaps between doses leave your dog unprotected, and in areas with heavy flea or tick pressure, even a short lapse can lead to a new infestation.